In conclusion, our study suggests that anti-RA33 (IgG) autoantibodies (anti-hnRNP/A2) occur in Saudi RA patients with very low diagnostic sensitivity (7.32%), which seems to be not representing as an additional immunodiagnostic marker in established RA. The gene discussed is HNRNPA2B1; the disease is rheumatoid arthritis.